![James Peyer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van James Peyer
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Aeonian Pharmaceuticals, Inc.
![]() Aeonian Pharmaceuticals, Inc. BiotechnologyHealth Technology Aeonian Pharmaceuticals, Inc. operates as a an R&D-stage biopharmaceutical company. It discovers, develops and commercializes innovative therapeutics for the treatment of rare and age-related diseases. The company is headquartered in San Francisco, CA. | Directeur/Bestuurslid | - | - |
Vita Therapeutics, Inc.
![]() Vita Therapeutics, Inc. BiotechnologyHealth Technology Vita Therapeutics, Inc. is a biotechnology company based in Baltimore, MD that develops state-of-the-art cellular therapeutics for the treatment of neuromuscular diseases and cancers. The company uses induced pluripotent stem cell (iPSC) technology to engineer specific cell types designed to replace those that are defective in patients. Vita Therapeutics is progressing its co-leading programs VTA-100 and VTA-300 for the treatment of limb-girdle muscular dystrophy (LGMD) and multiple solid tumors with the goal of filing investigational drug applications with the Food and Drug Administration in 2023. The company is developing these proprietary cellular therapies following a dual development strategy beginning with autologous-derived cells before moving to a universal hypoimmunogenic cell line. Vita Therapeutics was founded in 2019 by Douglas Taylor Falk, M.S. and Peter Andersen, Ph.D. Douglas Taylor Falk has been the CEO since 2019. | Directeur/Bestuurslid | - | - |
Loopbaan van James Peyer
Statistieken
Internationaal
Verenigde Staten | 3 |
Operationeel
Director/Board Member | 2 |
Sectoraal
Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Aeonian Pharmaceuticals, Inc.
![]() Aeonian Pharmaceuticals, Inc. BiotechnologyHealth Technology Aeonian Pharmaceuticals, Inc. operates as a an R&D-stage biopharmaceutical company. It discovers, develops and commercializes innovative therapeutics for the treatment of rare and age-related diseases. The company is headquartered in San Francisco, CA. | Health Technology |
Vita Therapeutics, Inc.
![]() Vita Therapeutics, Inc. BiotechnologyHealth Technology Vita Therapeutics, Inc. is a biotechnology company based in Baltimore, MD that develops state-of-the-art cellular therapeutics for the treatment of neuromuscular diseases and cancers. The company uses induced pluripotent stem cell (iPSC) technology to engineer specific cell types designed to replace those that are defective in patients. Vita Therapeutics is progressing its co-leading programs VTA-100 and VTA-300 for the treatment of limb-girdle muscular dystrophy (LGMD) and multiple solid tumors with the goal of filing investigational drug applications with the Food and Drug Administration in 2023. The company is developing these proprietary cellular therapies following a dual development strategy beginning with autologous-derived cells before moving to a universal hypoimmunogenic cell line. Vita Therapeutics was founded in 2019 by Douglas Taylor Falk, M.S. and Peter Andersen, Ph.D. Douglas Taylor Falk has been the CEO since 2019. | Health Technology |
- Beurs
- Insiders
- James Peyer
- Ervaring